Epidemiological impact and cost-effectiveness analysis of COVID-19 vaccination in Kenya
Stacey Orangi(Kenya Medical Research Institute), Edwine Barasa(Angkor Hospital for Children), Philip Bejon(Nuffield Orthopaedic Centre), J. Anthony G. Scott(Kenya Medical Research Institute), Kadondi Kasera(Ministry of Health), Charles N. Agoti(Kenya Medical Research Institute), Rashid Aman(King Abdullah University of Science and Technology), Morris Ogero(Kenya Medical Research Institute), Lynette Isabella Ochola‐Oyier(University of Nairobi), Samuel P. C. Brand(Institute for Forecasting of the Slovak Academy of Sciences), Mercy Mwangangi(Ministry of Health), Edward Otieno(Kenya Medical Research Institute), Stefan Flasche(London School of Hygiene & Tropical Medicine), Angela Kairu(Kenya Medical Research Institute), Patrick Amoth(Ministry of Health), Wangari Ng’ang’a(Kenya School of Government), Sophie Uyoga(Kenya Medical Research Institute), Ifedayo Adetifa(London School of Hygiene & Tropical Medicine), Matt J. Keeling(University of Warwick), D. James Nokes(Kenya Medical Research Institute), George M. Warimwe(Kenya Medical Research Institute), Ambrose Agweyu(Kenya Medical Research Institute), John Ojal(Kenya Medical Research Institute), Rabia Aziza(University of Warwick), Cameline Orlendo(Kenya Medical Research Institute)
Cited by 6
Related Papers
The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study
|The Lancet Public Health|2020|2.3k
Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
|The Lancet Infectious Diseases|2018|2k
Age-dependent effects in the transmission and control of COVID-19 epidemics
|Nature Medicine|2020|1.9k
RNA virus interference via CRISPR/Cas13a system in plants
|Genome biology|2018|1.5k